Raymond James & Associates Astrazeneca PLC Transaction History

Raymond James & Associates

  • $150 Billion
  • Q2 2024

A detailed history of Raymond James & Associates transactions in Astrazeneca PLC stock. As of the latest transaction made, Raymond James & Associates holds 2,576,736 shares of AZN stock, worth $200 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,576,736
Previous 2,584,540 0.3%
Holding current value
$200 Million
Previous $175 Million 14.77%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$66.81 - $80.83 $521,385 - $630,797
-7,804 Reduced 0.3%
2,576,736 $201 Million
Q1 2024

Apr 22, 2024
BUY
$61.03 - $69.57 $10.6 Million - $12 Million
173,048 Added 7.18%
2,584,540 $175 Million
Q4 2023

Jan 16, 2024
BUY
$61.89 - $69.28 $498,462 - $557,981
8,054 Added 0.34%
2,411,492 $162 Million
Q3 2023

Oct 24, 2023
SELL
$64.85 - $71.7 $14.6 Million - $16.1 Million
-224,887 Reduced 8.56%
2,403,438 $163 Million
Q2 2023

Jul 25, 2023
BUY
$69.91 - $75.81 $3.58 Million - $3.89 Million
51,255 Added 1.99%
2,628,325 $188 Million
Q1 2023

Apr 14, 2023
BUY
$63.15 - $71.6 $11.2 Million - $12.6 Million
176,673 Added 7.36%
2,577,070 $179 Million
Q4 2022

Feb 08, 2023
SELL
$54.21 - $70.44 $7.52 Million - $9.77 Million
-138,732 Reduced 5.46%
2,400,397 $163 Million
Q3 2022

Oct 25, 2022
BUY
$53.02 - $135.75 $4.19 Million - $10.7 Million
79,098 Added 3.22%
2,539,129 $139 Million
Q2 2022

Aug 12, 2022
BUY
$59.26 - $71.14 $6.94 Million - $8.34 Million
117,170 Added 5.0%
2,460,031 $163 Million
Q1 2022

May 11, 2022
BUY
$55.72 - $67.12 $11.5 Million - $13.8 Million
205,975 Added 9.64%
2,342,861 $155 Million
Q4 2021

Feb 08, 2022
SELL
$54.02 - $63.83 $1.98 Million - $2.34 Million
-36,666 Reduced 1.69%
2,136,886 $124 Million
Q3 2021

Nov 02, 2021
BUY
$55.56 - $60.79 $38.4 Million - $42 Million
690,494 Added 46.56%
2,173,552 $131 Million
Q2 2021

Aug 11, 2021
BUY
$48.42 - $60.18 $5.42 Million - $6.74 Million
111,962 Added 8.17%
1,483,058 $88.8 Million
Q1 2021

May 14, 2021
BUY
$47.16 - $54.44 $11.8 Million - $13.7 Million
250,773 Added 22.38%
1,371,096 $68.2 Million
Q4 2020

Feb 12, 2021
SELL
$48.52 - $58.02 $6.99 Million - $8.36 Million
-144,024 Reduced 11.39%
1,120,323 $56 Million
Q3 2020

Nov 04, 2020
SELL
$53.07 - $61.1 $5.09 Million - $5.86 Million
-95,839 Reduced 7.05%
1,264,347 $69.3 Million
Q2 2020

Jul 28, 2020
BUY
$43.1 - $55.31 $3.69 Million - $4.74 Million
85,623 Added 6.72%
1,360,186 $71.9 Million
Q1 2020

Apr 21, 2020
BUY
$37.79 - $51.33 $2.46 Million - $3.34 Million
65,010 Added 5.37%
1,274,563 $56.9 Million
Q4 2019

Feb 12, 2020
BUY
$42.46 - $50.46 $299,640 - $356,096
7,057 Added 0.59%
1,209,553 $60.3 Million
Q3 2019

Nov 07, 2019
SELL
$40.12 - $45.47 $2.95 Million - $3.35 Million
-73,643 Reduced 5.77%
1,202,496 $53.6 Million
Q2 2019

Aug 06, 2019
SELL
$37.28 - $41.68 $6.16 Million - $6.89 Million
-165,334 Reduced 11.47%
1,276,139 $52.7 Million
Q1 2019

May 06, 2019
SELL
$35.49 - $43.02 $41.9 Million - $50.8 Million
-1,180,055 Reduced 45.01%
1,441,473 $58.3 Million
Q4 2018

Feb 11, 2019
SELL
$36.86 - $41.49 $12.5 Million - $14 Million
-338,463 Reduced 11.43%
2,621,528 $99.6 Million
Q3 2018

Nov 14, 2018
SELL
$34.76 - $39.72 $20.5 Million - $23.5 Million
-590,646 Reduced 16.63%
2,959,991 $117 Million
Q2 2018

Aug 14, 2018
SELL
$34.55 - $37.05 $11.3 Million - $12.1 Million
-326,596 Reduced 8.42%
3,550,637 $125 Million
Q1 2018

May 14, 2018
SELL
$32.97 - $36.63 $13.6 Million - $15.1 Million
-413,129 Reduced 9.63%
3,877,233 $136 Million
Q4 2017

Feb 14, 2018
BUY
$32.09 - $34.78 $5.58 Million - $6.05 Million
174,031 Added 4.23%
4,290,362 $149 Million
Q3 2017

Nov 13, 2017
BUY
$28.96 - $34.0 $13.4 Million - $15.7 Million
462,537 Added 12.66%
4,116,331 $139 Million
Q2 2017

Aug 14, 2017
BUY
N/A
3,653,794
3,653,794 $125 Million

Others Institutions Holding AZN

# of Institutions
1,333
Shares Held
490M
Call Options Held
4.99M
Put Options Held
3.19M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $241B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email